UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021582
Receipt number R000024890
Scientific Title Efficacy and safety using optimization MMF of dosing by monitoring
Date of disclosure of the study information 2016/03/23
Last modified on 2019/03/14 14:00:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy and safety using optimization MMF of dosing by monitoring

Acronym

Efficacy and safety using optimization MMF of dosing by monitoring

Scientific Title

Efficacy and safety using optimization MMF of dosing by monitoring

Scientific Title:Acronym

Efficacy and safety using optimization MMF of dosing by monitoring

Region

Japan


Condition

Condition

Renal-transplant recipients and liver-transplant recipients and refractry GVHD

Classification by specialty

Hematology and clinical oncology Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To establish the proper dosage in the patients receiving MMF by monitoring.

Basic objectives2

Pharmacokinetics

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Pharmacokinetic analysis of MPAG and MPA

Key secondary outcomes

Efficacy and safety


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Mycophenolate Mofetil administration

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients who receive mycophenolate mofetil.

Key exclusion criteria

The patients who do not obtain consent for this study.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ryosei nishimura

Organization

Kanazawa universuty

Division name

Pediatrics

Zip code


Address

13-1 Takara-machi, Kanazawa, Ishikawa

TEL

076-265-2313

Email

pedialib@med.kanazawa-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hideaki Maeba

Organization

Kanazawa University

Division name

Pediatrics

Zip code


Address

13-1 Takara-machi, Kanazawa, Ishikawa

TEL

076-265-2313

Homepage URL


Email

pedialib@med.kanazawa-u.ac.jp


Sponsor or person

Institute

Department of Pediatrics, Kanazawa University.

Institute

Department

Personal name



Funding Source

Organization

Department of Pediatrics, Kanazawa University.

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 03 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2011 Year 07 Month 28 Day

Date of IRB

2011 Year 07 Month 28 Day

Anticipated trial start date

2011 Year 07 Month 28 Day

Last follow-up date

2018 Year 12 Month 26 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 03 Month 23 Day

Last modified on

2019 Year 03 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024890


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name